Soleus Capital Management, L.P. - NEUROPACE INC ownership

NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 25 filers reported holding NEUROPACE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of NEUROPACE INC
ValueSharesWeighting
Q3 2023$23,996,175
+116.7%
2,466,205
-0.0%
2.21%
+79.9%
Q2 2023$11,073,301
-1.7%
2,466,214
+1.5%
1.23%
+5.5%
Q1 2023$11,269,233
+219.3%
2,428,714
+2.5%
1.17%
+130.6%
Q4 2022$3,529,814
-59.7%
2,369,003
+1.5%
0.51%
-57.4%
Q3 2022$8,753,000
-24.2%
2,334,0030.0%1.19%
-34.0%
Q2 2022$11,553,000
-39.4%
2,334,003
+0.4%
1.80%
-26.8%
Q1 2022$19,080,000
-18.0%
2,324,003
+0.6%
2.46%
+5.7%
Q4 2021$23,275,000
-12.1%
2,309,003
+38.3%
2.33%
-43.5%
Q3 2021$26,472,000
-19.6%
1,670,136
+20.6%
4.12%
-18.6%
Q2 2021$32,935,0001,384,3875.06%
Other shareholders
NEUROPACE INC shareholders Q4 2022
NameSharesValueWeighting ↓
KCK LTD. 5,621,111$54,693,41077.70%
Soleus Capital Management, L.P. 2,466,205$23,996,1752.21%
Kent Lake Capital LLC 574,417$5,589,0772.15%
Nantahala Capital Management 1,219,915$11,869,7731.01%
Orbimed Advisors 4,012,281$39,039,4940.83%
EAM Investors, LLC 141,616$1,377,9240.27%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 60,048$584,2670.01%
Financial Advocates Investment Management 10,000$97,3000.01%
MORGAN STANLEY 2,399,716$23,349,2370.00%
FMR LLC 706,245$6,871,7650.00%
View complete list of NEUROPACE INC shareholders